Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent settlements
Pharma
Aurinia deal with Teva keeps Lupkynis generic in check until '36
Aurinia has struck a patent settlement with Teva that will likely ensure that Lupkynis will not face generic competition in the U.S. until late 2036.
Kevin Dunleavy
Aug 20, 2026 11:28am
SK settles with MSN over generic of seizure med Xcopri: reports
Aug 19, 2026 11:21am
Axsome bars generic rivals to narcolepsy med Sunosi until 2040
Jun 4, 2026 9:35am
Gilead inks Biktarvy settlements with 3 generic drug makers
Oct 7, 2025 7:40am
AbbVie settles lawsuit to ward off Rinvoq generics until 2037
Sep 11, 2025 1:36pm
GSK nabs $320M in CureVac patent settlement
Aug 8, 2025 10:46am
